193 related articles for article (PubMed ID: 24803739)
1. Inhibiting C-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent models.
Szalai AJ; McCrory MA; Xing D; Hage FG; Miller A; Oparil S; Chen YF; Mazzone M; Early R; Henry SP; Zanardi TA; Graham MJ; Crooke RM
Mediators Inflamm; 2014; 2014():353614. PubMed ID: 24803739
[TBL] [Abstract][Full Text] [Related]
2. Targeting C-reactive protein for the treatment of cardiovascular disease.
Pepys MB; Hirschfield GM; Tennent GA; Gallimore JR; Kahan MC; Bellotti V; Hawkins PN; Myers RM; Smith MD; Polara A; Cobb AJ; Ley SV; Aquilina JA; Robinson CV; Sharif I; Gray GA; Sabin CA; Jenvey MC; Kolstoe SE; Thompson D; Wood SP
Nature; 2006 Apr; 440(7088):1217-21. PubMed ID: 16642000
[TBL] [Abstract][Full Text] [Related]
3. Effects of antisense oligonucleotides against C-reactive protein on the development of atherosclerosis in WHHL rabbits.
Yu Q; Liu Z; Waqar AB; Ning B; Yang X; Shiomi M; Graham MJ; Crooke RM; Liu E; Dong S; Fan J
Mediators Inflamm; 2014; 2014():979132. PubMed ID: 24872601
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and cardiovascular diseases--is it ready for primetime?
Lavie CJ; Milani RV; Verma A; O'Keefe JH
Am J Med Sci; 2009 Dec; 338(6):486-92. PubMed ID: 20010156
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein predicts future cardiovascular events in patients with carotid stenosis.
Schlager O; Exner M; Mlekusch W; Sabeti S; Amighi J; Dick P; Wagner O; Koppensteiner R; Minar E; Schillinger M
Stroke; 2007 Apr; 38(4):1263-8. PubMed ID: 17322087
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies.
Kim TW; Kim KS; Seo JW; Park SY; Henry SP
J Pharmacol Toxicol Methods; 2014; 69(1):49-60. PubMed ID: 24211663
[TBL] [Abstract][Full Text] [Related]
7. [Effects of overexpression of human tissue inhibitor of metalloproteinase-1 on the inflammatory response in rats with myocardial infarction and related mechanisms].
Zhao LL; Song YQ; Zhang Y; Shi Y; Ren M; Liu S; Mao YM
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jun; 45(6):513-518. PubMed ID: 28648029
[No Abstract] [Full Text] [Related]
8. C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up.
Vanhaverbeke M; Veltman D; Pattyn N; De Crem N; Gillijns H; Cornelissen V; Janssens S; Sinnaeve PR
Clin Cardiol; 2018 Sep; 41(9):1201-1206. PubMed ID: 29952015
[TBL] [Abstract][Full Text] [Related]
9. The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
Celik T; Iyisoy A; Kursaklioglu H; Turhan H; Kilic S; Kose S; Amasyali B; Isik E
Coron Artery Dis; 2005 Aug; 16(5):293-9. PubMed ID: 16000887
[TBL] [Abstract][Full Text] [Related]
10. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
[TBL] [Abstract][Full Text] [Related]
11. Effect of statin treatment in patients with acute myocardial infarction and left ventricular systolic dysfunction according to the level of high-sensitivity C-reactive protein.
Jeong HC; Ahn Y; Park KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Kim YJ; Chae SC; Cho MC; Chae JK; Kim CJ; Rha SW; Jang YS; Oh SK; Seong IW; Cha KS
Int Heart J; 2014; 55(2):106-12. PubMed ID: 24632965
[TBL] [Abstract][Full Text] [Related]
12. A Selective Inhibitor of Human C-reactive Protein Translation Is Efficacious In Vitro and in C-reactive Protein Transgenic Mice and Humans.
Jones NR; Pegues MA; McCrory MA; Singleton W; Bethune C; Baker BF; Norris DA; Crooke RM; Graham MJ; Szalai AJ
Mol Ther Nucleic Acids; 2012 Nov; 1(11):e52. PubMed ID: 23629027
[TBL] [Abstract][Full Text] [Related]
13. CRP in cardiovascular disease.
Karakas M; Koenig W
Herz; 2009 Dec; 34(8):607-13. PubMed ID: 20024640
[TBL] [Abstract][Full Text] [Related]
14. Pre-operative high sensitive C-reactive protein predicts cardiovascular events after coronary artery bypass grafting surgery: a prospective observational study.
Balciunas M; Bagdonaite L; Samalavicius R; Griskevicius L; Vuylsteke A
Ann Card Anaesth; 2009; 12(2):127-32. PubMed ID: 19602737
[TBL] [Abstract][Full Text] [Related]
15. Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis.
Warren MS; Hughes SG; Singleton W; Yamashita M; Genovese MC
Arthritis Res Ther; 2015 Mar; 17(1):80. PubMed ID: 25885521
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm.
Sever PS; Poulter NR; Chang CL; Thom SA; Hughes AD; Welsh P; Sattar N;
J Am Coll Cardiol; 2013 Aug; 62(8):717-29. PubMed ID: 23948514
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction.
Griselli M; Herbert J; Hutchinson WL; Taylor KM; Sohail M; Krausz T; Pepys MB
J Exp Med; 1999 Dec; 190(12):1733-40. PubMed ID: 10601349
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial infarction treated with primary angioplasty.
Karpiński L; Płaksej R; Kosmala W; Witkowska M
Kardiol Pol; 2008 Dec; 66(12):1279-85. PubMed ID: 19169974
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein-mediated vascular injury requires complement.
Hage FG; Oparil S; Xing D; Chen YF; McCrory MA; Szalai AJ
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1189-95. PubMed ID: 20339115
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
